A Surgical Window Trial Evaluating Medroxyprogesterone Acetate with or without Entinostat in Patients with Endometrial Cancer and Validation of Biomarkers of Cellular Response

OBJECTIVE: This surgical window of opportunity (window) study assessed short-term effect of medroxyprogesterone acetate (MPA) alone vs MPA plus histone deacetylase (HDAC) inhibitor entinostat on regulation of progesterone receptor (PR) in women with newly diagnosed endometrioid endometrial adenocarc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Duska, Linda R., Filiaci, Virginia L., Walker, Joan L., Holman, Laura L., Hill, Emily K., Moore, Richard G., Ring, Kari, Pearl, Michael L., Muller, Carolyn Y., Kushnir, Christina L., Lankes, Heather A., Samuelson, Megan I., Carrick, Kelley S., Rajan, Anand, Rodgers, William H., Kohn, Elise C., Piekarz, Richard, Leslie, Kimberly K.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8127359/
https://ncbi.nlm.nih.gov/pubmed/33766814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-4618
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares